Related Experiment Video
Updated: Apr 28, 2026
05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
8.1K
The UVA/PADOVA Type 1 Diabetes Simulator: New Features.
Chiara Dalla Man1, Francesco Micheletto1, Dayu Lv2
1Department of Information Engineering, University of Padova, Padova, Italy.
Journal of Diabetes Science and Technology
|May 31, 2014
Summary
The updated UVA/PADOVA Type 1 Diabetes Simulator (S2013) better models hypoglycemia by incorporating nonlinear insulin action and glucagon kinetics, improving virtual patient representation for diabetes research.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Endocrinology
Background:
- Previous diabetes simulators lacked detailed modeling of hypoglycemia and glucagon dynamics.
- Understanding nonlinear insulin action in the hypoglycemic range is crucial for Type 1 Diabetes (T1D) management.
Purpose of the Study:
- To develop an improved version of the UVA/PADOVA Type 1 Diabetes Simulator (S2013) with enhanced glucose and glucagon kinetics.
- To refine virtual patient generation and ensure better representation of the T1D population.
Main Methods:
- Incorporated nonlinear insulin-dependent glucose utilization below a specific glucose threshold.
- Integrated models for glucagon kinetics, secretion (influenced by insulin, glucose, and glucose rate of change), and action on endogenous glucose production.
- Implemented a refined statistical strategy for virtual patient generation and updated rules for insulin-to-carbohydrate ratio (CR) and correction factor (CF).
Main Results:
- The S2013 simulator demonstrates improved performance in simulating hypoglycemic events.
- Generated virtual subjects accurately represent the real-world T1D population, with good agreement in patient-specific parameters like CR and CF.
- The enhanced model provides a more reliable framework for in silico trials and device testing.
Conclusions:
- The S2013 simulator offers a more robust platform for in silico trials, glucose sensor testing, and closed-loop controller development in Type 1 Diabetes.
- The improved modeling of hypoglycemia and glucagon kinetics enhances the simulator's accuracy and applicability for T1D research.
More Related Videos
Related Concept Videos
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:26Type I Diabetes II: Pathophysiology
68
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
68
01:26Type II Diabetes I: Introduction
13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
01:22Diabetes Mellitus: Overview and Type I Subtype
5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
01:26Diabetes Mellitus: Introduction
22
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
22
01:19Type I Diabetes III: Clinical Manifestations
21
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
21